Literature DB >> 3732998

Multivariate analysis of prognostic factors in fulminant hepatitis B.

J Bernuau, A Goudeau, T Poynard, F Dubois, G Lesage, B Yvonnet, C Degott, A Bezeaud, B Rueff, J P Benhamou.   

Abstract

We assessed prognostic factors in 115 patients with serologically defined fulminant hepatitis B. The diagnosis in each case was based on the finding of IgM antibody to the hepatitis B core antigen in serum. Multivariate analysis showed that factor V level (p less than 0.001), patient's age (p = 0.001), absence of detectable HBsAg by radioimmunoassay (p = 0.06) and serum alpha-fetoprotein concentration (p = 0.07) were independent predictors of survival. The survival rate in the 21 patients in whom HBsAg was not detected was 47%, which was significantly higher than the survival rate of 17% observed in the 94 HBsAg-positive patients (p = 0.006). In patients with fulminant hepatitis B, the absence of HBsAg in serum as detected by radioimmunoassay has an independent, favorable prognostic value.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3732998     DOI: 10.1002/hep.1840060417

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  56 in total

1.  Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.

Authors:  J Devlin; J O'Grady
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

2.  Portal hemodynamics in fulminant hepatic failure as assessed by duplex Doppler ultrasonography.

Authors:  Y Chawla; A Sreedharan; R K Dhiman; S Jain; S Suri
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

Review 3.  Fulminant hepatic failure. Clinical features, etiology, epidemiology, and current management.

Authors:  L Capocaccia; M Angelico
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

4.  Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation.

Authors:  Christophe Camus; Sylvain Lavoué; Arnaud Gacouin; Yves Le Tulzo; Richard Lorho; Karim Boudjéma; Christian Jacquelinet; Rémi Thomas
Journal:  Intensive Care Med       Date:  2006-08-29       Impact factor: 17.440

5.  Low serum factor V level: early predictor of allograft failure and death following liver transplantation.

Authors:  Mauricio C Zulian; Marcio F Chedid; Aljamir D Chedid; Tomaz J M Grezzana Filho; Ian Leipnitz; Alexandre de Araujo; Mario R Alvares-da-Silva; Mario G Cardoni; Luciano S Guimaraes; Cleber D P Kruel; Cleber R P Kruel
Journal:  Langenbecks Arch Surg       Date:  2015-02-24       Impact factor: 3.445

6.  [4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009].

Authors:  Markus Peck-Radosavljevic; Johann Deutsch; Peter Ferenci; Ivo Graziadei; Harald Hofer; Heidemarie Holzmann; Wolf-Dietrich Huber; Herman Laferl; Andreas Maieron; Rudolf Stauber; Wolfgang Vogel
Journal:  Wien Klin Wochenschr       Date:  2010-05-04       Impact factor: 1.704

Review 7.  Etiology and management of fulminant hepatic failure.

Authors:  Javier Vaquero; Andres T Blei
Journal:  Curr Gastroenterol Rep       Date:  2003-02

8.  Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period.

Authors:  Douglas G Farmer; Dean M Anselmo; R Mark Ghobrial; Hasan Yersiz; Suzanne V McDiarmid; Carlos Cao; Michael Weaver; Jesus Figueroa; Khurram Khan; Jorge Vargas; Sammy Saab; Steven Han; Francisco Durazo; Leonard Goldstein; Curtis Holt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

9.  Heparin-like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation.

Authors:  Marco Senzolo; Seema Agarwal; Paola Zappoli; Sushang Vibhakorn; Susan Mallett; Andrew K Burroughs
Journal:  Liver Int       Date:  2009-02-09       Impact factor: 5.828

10.  Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis.

Authors:  X Ren; Z Xu; Y Liu; X Li; S Bai; N Ding; Y Zhong; L Wang; P Mao; F Zoulim; D Xu
Journal:  J Viral Hepat       Date:  2010-12       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.